These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
132 related articles for article (PubMed ID: 8388582)
21. Deep venous thrombosis: low-molecular-weight heparins in perioperative prophylaxis. Merli G Cleve Clin J Med; 1995; 62(6):368-9. PubMed ID: 8556807 [No Abstract] [Full Text] [Related]
22. [Efficacy and tolerance of low molecular weight heparin in the prevention of deep venous thrombosis during non-emergent total hip arthroplasty. A prospective, multicenter trial]. Simon P; Kindermans A; Kempf JF; Postel M J Chir (Paris); 1990 May; 127(5):252-7. PubMed ID: 2165076 [TBL] [Abstract][Full Text] [Related]
23. Prevention and therapy of postoperative thrombosis and embolism. Röggla M; Wagner A; Malzer R; Gamper G; Janata K; Röggla G Acta Anaesthesiol Scand Suppl; 1997; 111():217-9. PubMed ID: 9421020 [No Abstract] [Full Text] [Related]
24. [Prevention of thrombosis with low molecular weight heparin as the only substance and/or with DHE: results of clinical studies]. Koppenhagen K; Tröster E; Matthes M; Häring R Langenbecks Arch Chir Suppl II Verh Dtsch Ges Chir; 1990; ():1163-6. PubMed ID: 1983504 [TBL] [Abstract][Full Text] [Related]
25. Low molecular weight heparin and unfractionated heparin in thrombosis prophylaxis after major surgical intervention: update of previous meta-analyses. Koch A; Bouges S; Ziegler S; Dinkel H; Daures JP; Victor N Br J Surg; 1997 Jun; 84(6):750-9. PubMed ID: 9189079 [TBL] [Abstract][Full Text] [Related]
26. Optimal low-molecular-weight heparin regimen in major orthopaedic surgery. A meta-analysis of randomised trials. Zufferey P; Laporte S; Quenet S; Molliex S; Auboyer C; Decousus H; Mismetti P Thromb Haemost; 2003 Oct; 90(4):654-61. PubMed ID: 14515186 [TBL] [Abstract][Full Text] [Related]
27. [Defibrotide and heparin in the prevention of deep venous thromboses. A controlled study]. Villani LG; Dalla Valle R; Rubini P Minerva Chir; 1990 Aug; 45(15-16):1029-33. PubMed ID: 2280855 [TBL] [Abstract][Full Text] [Related]
28. ["How must deep leg venous thrombosis be diagnosed and treated?"]. Bruhn HD Dtsch Med Wochenschr; 2003 Aug; 128(33):1730-1. PubMed ID: 12920673 [No Abstract] [Full Text] [Related]
29. When can the patient with deep venous thrombosis begin to ambulate? Aldrich D; Hunt DP Phys Ther; 2004 Mar; 84(3):268-73. PubMed ID: 14984299 [No Abstract] [Full Text] [Related]
30. Treatment of venous thromboembolism: unfractionated heparin or low molecular weight heparins? Agnelli G Haematologica; 1995; 80(2 Suppl):78-83. PubMed ID: 7628776 [No Abstract] [Full Text] [Related]
31. [The use of enoxaparine in preventing deep venous thrombosis following total hip prosthesis. Randomized multicenter prospective trial]. Planes A; Vochelle N; Mazas F; Mansat C; Zucman J; Landais A; Pascariello JC; Weil D; Butel J Rev Chir Orthop Reparatrice Appar Mot; 1988; 74 Suppl 2():215-8. PubMed ID: 2852830 [No Abstract] [Full Text] [Related]
32. [Improved postoperative prevention of thrombosis in trauma surgery by dose adjusted low molecular weight heparin based on TAT and D-dimer values]. Hansen M; Mayer A; Peetz D; Hafner G; Prellwitz W; Rommens PM Langenbecks Arch Chir Suppl Kongressbd; 1998; 115():1213-7. PubMed ID: 9931839 [No Abstract] [Full Text] [Related]
33. [Meta-analysis on randomized trials comparing the results of low-molecular weight heparins to those of fractioned heparins in the prevention of deep venous thrombosis]. Daures JP; Schved JF; Momas I; Gril JC; Azoulay P; Gremy F Rev Epidemiol Sante Publique; 1989; 37(4):363-9. PubMed ID: 2558404 [TBL] [Abstract][Full Text] [Related]
34. [Prevention of thrombosis in gynecology: double-blind comparison of low molecular weight heparin and unfractionated heparin]. Heilmann L; Kruck M; Schindler AE Geburtshilfe Frauenheilkd; 1989 Sep; 49(9):803-7. PubMed ID: 2553528 [TBL] [Abstract][Full Text] [Related]
35. Subcutaneous low-molecular weight heparin or oral anticoagulants for the prevention of deep-vein thrombosis in elective hip and knee replacement? Fraxiparine Oral Anticoagulant Study Group. Hamulyák K; Lensing AW; van der Meer J; Smid WM; van Ooy A; Hoek JA Thromb Haemost; 1995 Dec; 74(6):1428-31. PubMed ID: 8772214 [TBL] [Abstract][Full Text] [Related]
37. Venography in deep venous thrombosis: postoperative screening of patients in prophylaxis studies. Borris LC; Lassen MR Haemostasis; 1993 Mar; 23 Suppl 1():80-4. PubMed ID: 8388356 [TBL] [Abstract][Full Text] [Related]
38. Venous thromboprophylaxis in the 1990s: a perspective. Fareed J Semin Thromb Hemost; 1991 Oct; 17(4):317-21. PubMed ID: 1666451 [No Abstract] [Full Text] [Related]
39. [Prevention of thromboembolism in surgery--results of a survey in West German hospitals]. Klempa I; Baca I; Menzel J; Rasche H Chirurg; 1992 Jun; 63(6):501-5. PubMed ID: 1322816 [TBL] [Abstract][Full Text] [Related]
40. Low doses of heparin and heparin dihydergot in postoperative thromboprophylaxis in gynaecological patients. Urlep-Salinović V; Jelatancev B; Gorisek B Thromb Haemost; 1994 Jul; 72(1):16-20. PubMed ID: 7974365 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]